Peter Sidaway

1.4k total citations
267 papers, 1.1k citations indexed

About

Peter Sidaway is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Sidaway has authored 267 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 74 papers in Molecular Biology and 71 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Sidaway's work include Cancer Immunotherapy and Biomarkers (32 papers), Cancer Genomics and Diagnostics (23 papers) and CAR-T cell therapy research (18 papers). Peter Sidaway is often cited by papers focused on Cancer Immunotherapy and Biomarkers (32 papers), Cancer Genomics and Diagnostics (23 papers) and CAR-T cell therapy research (18 papers). Peter Sidaway collaborates with scholars based in United States, United Kingdom and Germany. Peter Sidaway's co-authors include Julie Sanderson, Nuwan Niyadurupola, David C. Broadway, Jeremy D. Rhodes, Ning Ma, Andrew Osborne, Julie A. Eldred, Lixin Wang, I. Michael Wormstone and John R. Reddan and has published in prestigious journals such as Nature reviews. Immunology, PLoS ONE and Nature Physics.

In The Last Decade

Peter Sidaway

250 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Sidaway United States 13 435 404 192 191 171 267 1.1k
Guido Giordano Italy 16 493 1.1× 267 0.7× 179 0.9× 225 1.2× 129 0.8× 76 916
Dong Kuang China 20 340 0.8× 525 1.3× 187 1.0× 248 1.3× 132 0.8× 67 1.2k
Di Jia China 16 259 0.6× 500 1.2× 275 1.4× 171 0.9× 148 0.9× 48 1.1k
Efstathia Giannopoulou Greece 20 297 0.7× 561 1.4× 129 0.7× 277 1.5× 98 0.6× 44 1.0k
Vito Barbieri Italy 22 628 1.4× 671 1.7× 171 0.9× 279 1.5× 193 1.1× 46 1.5k
Shelley M. Herbrich United States 14 544 1.3× 602 1.5× 145 0.8× 210 1.1× 386 2.3× 35 1.4k
Shawna Organ Canada 8 305 0.7× 520 1.3× 226 1.2× 179 0.9× 96 0.6× 9 976
Justin Bottsford-Miller United States 16 591 1.4× 559 1.4× 163 0.8× 324 1.7× 258 1.5× 42 1.4k
Lucas Wong United States 16 685 1.6× 429 1.1× 247 1.3× 124 0.6× 187 1.1× 50 1.3k
Nicole E. Willmarth United States 17 496 1.1× 671 1.7× 139 0.7× 390 2.0× 164 1.0× 23 1.2k

Countries citing papers authored by Peter Sidaway

Since Specialization
Citations

This map shows the geographic impact of Peter Sidaway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sidaway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sidaway more than expected).

Fields of papers citing papers by Peter Sidaway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sidaway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sidaway. The network helps show where Peter Sidaway may publish in the future.

Co-authorship network of co-authors of Peter Sidaway

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sidaway. A scholar is included among the top collaborators of Peter Sidaway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sidaway. Peter Sidaway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sidaway, Peter. (2024). Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer. Nature Reviews Clinical Oncology. 21(6). 402–402. 2 indexed citations
2.
Sidaway, Peter. (2024). MRI-based stratification reduces the risk of overdiagnosis of prostate cancer. Nature Reviews Clinical Oncology. 21(12). 838–838. 1 indexed citations
3.
Sidaway, Peter. (2023). Sacituzumab govitecan improves OS in heavily pretreated patients. Nature Reviews Clinical Oncology. 20(11). 734–734.
4.
Sidaway, Peter. (2023). Radiotherapy can be omitted for older patients with low-risk disease. Nature Reviews Clinical Oncology. 20(4). 210–210. 3 indexed citations
5.
Sidaway, Peter. (2023). Tovorafenib effective against low-grade gliomas harbouring BRAF fusions. Nature Reviews Clinical Oncology. 21(2). 83–83. 3 indexed citations
6.
Sidaway, Peter. (2022). LAG3 inhibition improves outcomes. Nature Reviews Clinical Oncology. 19(3). 149–149. 8 indexed citations
7.
Sidaway, Peter. (2022). From AACR 2022. Nature Reviews Clinical Oncology. 19(6). 359–359.
8.
Sidaway, Peter. (2021). Axicabtagene effective in indolent NHL. Nature Reviews Clinical Oncology. 19(3). 150–150. 1 indexed citations
9.
Sidaway, Peter. (2021). SBRT feasible for oligometastatic RCC. Nature Reviews Clinical Oncology. 19(1). 6–6. 1 indexed citations
10.
Sidaway, Peter. (2021). BRAF-mutant ctDNA predicts outcomes. Nature Reviews Clinical Oncology. 18(5). 258–258. 2 indexed citations
11.
Sidaway, Peter. (2021). ADC sacituzumab govitecan shows efficacy and safety. Nature Reviews Urology. 18(7). 384–384. 1 indexed citations
12.
Sidaway, Peter. (2021). 177Lu–PSMA-PET extends survival. Nature Reviews Urology. 18(9). 510–510.
13.
Sidaway, Peter. (2020). HER2-targeted agents overcome resistance. Nature Reviews Clinical Oncology. 17(3). 133–133. 6 indexed citations
14.
Sidaway, Peter. (2019). New targeted agents for urothelial carcinoma. Nature Reviews Clinical Oncology. 16(10). 591–591. 1 indexed citations
15.
Sidaway, Peter. (2019). MSI-H: a truly agnostic biomarker?. Nature Reviews Clinical Oncology. 17(2). 68–68. 17 indexed citations
16.
Sidaway, Peter. (2018). Genomics reveals distinct gastric cancer subtypes. Nature Reviews Clinical Oncology. 15(8). 470–470. 3 indexed citations
17.
Sidaway, Peter. (2018). MRI improves diagnosis. Nature Reviews Clinical Oncology. 15(6). 345–345. 9 indexed citations
18.
Sidaway, Peter. (2018). Immunotherapy-responsive gastric cancers identified. Nature Reviews Clinical Oncology. 15(10). 590–590. 3 indexed citations
19.
Sidaway, Peter. (2018). Immunoscore provides a more accurate prognosis. Nature Reviews Clinical Oncology. 15(8). 471–471. 13 indexed citations
20.
Sidaway, Peter. (2015). Nicotinamide reduces new skin cancer risk. Nature Reviews Clinical Oncology. 13(1). 4–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guido Giordano Breakdown of academic impact, for papers by Dong Kuang Breakdown of academic impact, for papers by Di Jia Breakdown of academic impact, for papers by Efstathia Giannopoulou Breakdown of academic impact, for papers by Vito Barbieri Breakdown of academic impact, for papers by Shelley M. Herbrich Breakdown of academic impact, for papers by Shawna Organ Breakdown of academic impact, for papers by Justin Bottsford-Miller Breakdown of academic impact, for papers by Lucas Wong Breakdown of academic impact, for papers by Nicole E. Willmarth
Rankless by CCL
2026